World-leading scientists from the Infection and Global Health Division reveal a new Tuberculosis (TB) drug that will shorten the treatment of the disease by up to 2 months, potentially saving millions of lives. Dr Muge…
Globally, Tuberculosis (TB) is the leading cause of death from a single infectious disease agent. Our sustained research in St Andrews over the last 10 years (on the disease and the pathogen responsible) has developed…
Dr Derek Sloan is working closely with colleagues at the Infectious Diseases Institute at Makerere University in Kampala, Uganda, in order to develop a series of adverts and programmes for Ugandan television about…
The ongoing Ebola outbreak in DR Congo continues to present challenges, not only to those who are directly affected, but to neighbouring countries. Dr Sloan, a Senior Clinical Lecturer in the School of Medicine at the…
Scientists at the School of Medicine are leading the medical monitoring of a new clinical trial to treat tuberculosis more quickly.
the first ever Molecular bacterial load assay (MBLA) stakeholders conference was held at the University of St Andrews, 11th – 13th June 2018.
Dr Wilber Sabiiti and Dr Derek Sloan recently represented the University of St Andrews at the 8th EDCTP forum.